As the initial results for the first of the two-step prompts for “aldehyde dehydrogenase 2 deficiency” resulted in more abstract images, the trial was run again using “ALDH2 deficiency” instead in May 2024. The gene discussed is ALDH2; the disease is hyperinsulinemic hypoglycemia, familial, 4.